期刊文献+

胃癌组织中hPOT1和p53表达及其临床意义 被引量:1

Expression of hPOT1 and p53 in gastric cancer tissue and their clinical significance
下载PDF
导出
摘要 目的探讨人端粒保护蛋白1(hPOT1)和p53在胃癌发生发展中的作用及机制。方法采用免疫组化SP法检测53份胃癌组织标本(观察组)及10份正常胃黏膜组织标本(对照组)hPOT1和p53蛋白表达;分析其与胃癌病理参数的关系。结果观察组hPOT1和p53蛋白阳性率均显著高于对照组P<0.05;hPOT1表达与胃癌组织学分型、分化程度及浸润深度有关(P<0.05)。p53表达与肿瘤浸润深度有关,P<0.05;观察组hPOT1与p53蛋白表达呈正相关,P<0.05。结论 hPOT1和p53参与了胃癌的发生、发展;联合检测hPOT1和p53蛋白表达有助于判断胃癌患者的预后。 ObjectiveTo investigate the roles and mechanism of human protection of telomeres(hPOT1) and p53 in the occurrence and development of gastric cancer.MethodsThe expression of hPOT1 and p53 protein were detected by SP immunohistochemical method in 53 gastric cancer specimens(observed group) and 10 normal gastric mucosa(control group);the correlation between the indexes and pathological parameters were analyzed.ResultsThe positive rate of hPOT1 and p53 protein in the observed group were both significantly higher than those in the control group(P0.05).The expression of hPOT1 was significantly correlated with histological type,differentiation and depth of invasion in gastric cancer(P0.05).The expression of p53 was significantly correlated with the depth of invasion in gastric cancer(P0.05).The expression of hPOT1 was positively correlated with the expression of p53 in the observed group(P0.05).ConclusionshPOT1 and p53 are associated with the occurrence and development of gastric cancer;combined detection of the expression of hPOT1 and p53 protein plays an important role in predicting the prognosis of patients with gastric cancer.
出处 《山东医药》 CAS 北大核心 2011年第7期4-6,共3页 Shandong Medical Journal
基金 贵州省优秀青年科技人才培养计划资助项目[黔科合人字(2005)0512号]
关键词 胃肿瘤 胃癌 端粒保护蛋白1 P53 免疫组织化学 gastric tumor gastric cancer human protection of telomeres p53 immunohistochemistry
  • 相关文献

参考文献6

二级参考文献118

  • 1An Gao Xu Shao Guang Li Ji Hong Liu Ai Hua Gan Research Laboratory of Digestive Disease,Huizhou Central People’s Hospital,Huizhou 516001,Guangdong Province,ChinaDr.An Gao Xu graduated from Guangdong Medical College in 1984.He is an associate physician-in-chief,specializing in the research and treatment of gastrointestinal and liver tumors.He has published 24 papers and 1 book..Function of apoptosis and expression of the proteins Bcl-2,p53 and C-myc in the development of gastric cancer[J].World Journal of Gastroenterology,2001,7(3):403-406. 被引量:91
  • 2屈涛.血清半胱氨酸、维生素B2水平与食管癌及胃贲门癌相关[J].中国医学论坛报,肿瘤专刊,2001,.
  • 3李连弟,鲁凤珠,张思维,牧人,孙秀娣,皇甫小梅,孙杰,周有尚,欧阳宁慧,饶克勤,陈育德,孙爱明,薛志福,夏毅.中国恶性肿瘤死亡率20年变化趋势和近期预测分析[J].中华肿瘤杂志,1997,19(1):3-9. 被引量:869
  • 4[1]Tamura G,Kihana T,Nomura K,Terada M,Sugimura T,Hirohashi S.Detection of frequent p53 gene mutations in primary gastric cancer by cell sorting and polymerase chain reaction single-strand conformation polymorphism analysis.Cancer Res 1991; 51:3056-3058
  • 5[2]Becker KF,Atkinson MJ,Reich U,Becker I,Nekarda H,Siewert JR,Hofler H.E-cadherin gene mutations provide clues to diffuse type gastric carcinomas.Cancer Res 1994; 54:3845-3852
  • 6[3]Tamura G,Sakata K,Nishizuka S,Maesawa C,Suzuki Y,Iwaya T,Terashima M,Saito K,Satodate R.Inactivation of the E-cadherin gene in primary gastric carcinomas and gastric carcinoma cell lines.Jpn J Cancer Res 1996; 87:1153-1159
  • 7[4]Kim IJ,Kang HC,Shin Y,Park HW,Jang SG,Han SY,Lim SK,Lee MR,Chang HJ,Ku JL,Yang HK,Park JG.A TP53-truncating germline mutation (E287X) in a family with characteristics of both hereditary diffuse gastric cancer and LiFraumeni syndrome.J Hum Genet 2004; 49:591-595
  • 8[5]Guilford P,Hopkins J,Harraway J,McLeod M,McLeod N,Harawira P,Taite H,Scoular R,Miller A,Reeve AE.E-cadherin germline mutations in familial gastric cancer.Nature 1998; 392:402-405
  • 9[6]Tamura G,Yin J,Wang S,Fleisher AS,Zou T,Abraham JM,Kong D,Smolinski KN,Wilson KT,James SP,Silverberg SG,Nishizuka S,Terashima M,Motoyama T,Meltzer SJ.E-Cadherin gene promoter hypermethylation in primary human gastric carcinomas.JNatl Cancer Inst 2000; 92:569-573
  • 10[7]Nishizuka S,Tamura G,Terashima M,Satodate R.Loss of heterozygosity during development and progression of differentiated adenocarcinoma of the stomach.J Pathol 1998;185:3843

共引文献820

同被引文献7

  • 1帖君,房殿春.POT1与端粒[J].重庆医学,2005,34(9):1429-1431. 被引量:2
  • 2Wan SM,Tie J ,Zhang YF, et al. Silencing of the hPOT1 gene by RNA inference promotes apoptosis and inhibits proliferation and aggressive phenotype of gastric cancer cells, likely through up regulating PinX1 expression[J]. J Clin Pathol, 2011,64 (12) : 1051-1057.
  • 3Possemato R, Timmons JC, Bauerlein El., et a l. Suppression of hPOTI in diploid human cells results in an hTERT-dependent alteration of telomere length dynamics [J]. Mol Cancer Res, 2008,6(10) : 1582-1593.
  • 4Kondo T,()ue N,Yoshida K,et al. Expression of POT1 is associated with tumor stage and telomere length in gastric carcinoma[J]. Cancer Res, 2004,64 (2) : 523-529.
  • 5Yang Q, Zheng YL, Harris CC. POTI and TRF2 cooperate to maintain telomeric integrity[J]. Mol Cell Biol, 2005,25 (3) : 1070-1080.
  • 6Gao J, Zhang J, Long Y, et al. Expression of telomere binding proteins in gastric cancer and correlation with clinieopatho- logical paramet ers[J]. Asia Pac J Clin Oncol, 2011,7 ( 4 ) : 339- 345.
  • 7袁荣高,杨留才,刘德军,李仕红,徐红涛.淋巴细胞中POT1 mRNA表达、端粒酶活性与2型糖尿病发生发展的关系[J].南京医科大学学报(自然科学版),2011,31(4):483-486. 被引量:1

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部